Why we can’t let cannabis become the next Big Tobacco
“Transnational tobacco companies have also sought to diversify into other products… British American Tobacco has bought a nearly 20% stake (US$ 175.8m) in Canadian cannabis producer Organigram, while Altria (parent company of Philip Morris USA) has invested US$1.8bn for a 45% stake in Cronos, one of the “Big Four” of the Canadian cannabis industry… It is vital that lessons are learnt from decades of tobacco industry lies and manipulation, and the valiant efforts of tobacco control advocates, research, and policy makers to push back against them.” From BMJ Opinion
Comment: Big Tobacco is a drug company willing to sell alternative drug products and even produce treatments for those experiencing consequences from their products. Their actions show they are no normal business enterprise. Stephen Hamann
Benoit Gomis: Why we can’t let cannabis become the next Big Tobacco
—
Stephen Hamann
